GPAtlas🧭 When to suspect
Around half of all cancers present with non-specific but concerning symptoms rather than a classic alarm symptom:
• Unexplained weight loss
• Fatigue or malaise
• Vague pain
• Persistently abnormal blood tests
Taken individually these have a low predictive value and usually fall below the 3% positive-predictive-value threshold that triggers a site-specific urgent suspected cancer pathway referral (previously the two-week wait).
This is exactly the group that historically did badly:
• Consulted repeatedly
• Referred late or diagnosed only after an emergency presentation
• Reached secondary care with more advanced disease
The clinical skill is to recognise that risk rises steeply with:
• Age
• Symptom combinations
• A “soft” blood marker
• A clinician’s gut feeling
Then use the right route. Two routes exist:
• A site-specific suspected cancer pathway when an alarm feature is present
• The Non-Specific Symptoms (NSS) pathway or Rapid Diagnostic Centre (RDC) when symptoms are concerning but do not point to one organ
Both sit under the Faster Diagnosis Standard: cancer diagnosed or excluded within 28 days of referral.
| Concerning non-specific feature | Why it matters · action |
|---|---|
| Unexplained weight loss | In adults ≥ 60 (mean loss > 5% of body weight over ~6 months) reaches the action threshold. • A feature of colorectal, gastro-oesophageal, lung, prostate, pancreatic and urological cancer. • Assess for additional features, then urgent investigation, a suspected-cancer pathway, or an NSS/RDC referral. |
| Unexplained appetite loss | • Associated with lung, oesophageal, stomach, colorectal, pancreatic, bladder and renal cancer • Assess for additional features, then urgent investigation or a suspected-cancer pathway referral |
| Persistent fatigue or malaise | • Low value alone – gains weight when combined with another symptom, a soft blood marker, or older age • Exclude common reversible causes first |
| New, unexplained vague pain | • Abdominal, back or bone pain, typically ≥ 4 weeks (less if marked concern) • Investigate per associated features (e.g. faecal immunochemical test [FIT], imaging, myeloma screen) |
| Unprovoked DVT or PE | • Associated with several cancers (urogenital, breast, colorectal, lung) • History, examination and basic bloods, then urgent investigation or a suspected-cancer pathway referral |
| Clinician “gut feeling” | An evidence-based predictor of serious disease – on its own a legitimate trigger for an NSS/RDC referral. |
Source: NICE NG12 · NHS England
🔒 Sign up free to read the full topic
You're viewing a free preview. Create a free account to unlock the rest.
Sign up free →Sample topics are open to everyone in the Free Sample Bundle.